-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
Thymidine-[5'-13C]
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/240407-53-8.gif)
| Category | Orthopoxvirus |
| CAS | 240407-53-8 |
| Description | As the labelled form of Thymidine, Thymidine-[5'-13C] is a constituent of deoxyribonucleic acid. |
Product Information
| Synonyms | 1-(2-Deoxy-β-D-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione-5'-13C; 1-(2-deoxy-β-D-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-Pyrimidinedione-5'-13C; 2'-Deoxythymidine-5'-13C; 5-Methyl-2'-deoxyuridine-5'-13C |
| IUPAC Name | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxy(1-13C)methyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione |
| Molecular Weight | 243.22 |
| Molecular Formula | C9[13C]H14N2O5 |
| Canonical SMILES | CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O |
| InChI | InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1/i4+1 |
| InChIKey | IQFYYKKMVGJFEH-CJLSWCASSA-N |
| Purity | 95% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
| PSA | 104.55000 |
| Target | DNA/RNA Synthesis; Endogenous Metabolite; Orthopoxvirus |
